Medical roundup

  • New Mercatus report on certificate-of-need laws, which operate to suppress competition in health care;
  • “Hospitals don’t dispense perfectly safe but expired drugs because that may expose them to regulatory penalties or lawsuits.” [Mike Riggs, Reason]
  • California unions push law setting minimum staffing requirements for dialysis centers [L.A. Times]
  • Glaxo neither made nor sold the pill he took, jury tells it to pay $3 million anyway [Roni Caryn Rabin, New York Times]
  • Maryland and Michigan suits seek to characterize patient falls as non-medical negligence; Kentucky suit aims to avoid medical review panel requirement [Andis Robeznieks, AMA Wire]
  • “Ohio Drug Price Initiative Gives Taxpayer Money to Unnecessary Lawyers” [Hans Bader, CEI]

One Comment

  • In that Glaxo article: it seems that Glaxo also wanted to put a stronger warning on the drug while they produced it but were prevented by the FDA?

    Glaxo: We have a great drug that will improve and save lives.
    Glaxo: Maybe it is not as great as we thought let’s warn people.just in case.
    FDA: No! We will tell you what is safe.
    Glaxo: OK, then we will stop making it so that we won’t injure anyone.
    Courts: You are still responsible for any injuries caused by others making a profit from it.
    Glaxo: So why do we bother trying to come up with new drugs?